Dibutyryladenosine cyclic 3',5'-monophosphate

CAS: 362-74-3

Rif. 3D-NR145431

Informazioni sul prodotto

• Nome: Dibutyryladenosine cyclic 3',5'-monophosphate
• Sinonimi: BucladesineDibutyryl 3',5'-cyclic AMP, (4aR,7R,7aR)-6-[6-(butanoylamino)-9H-purin-9-yl]-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate, 3',5'-Cyclic AMP dibutyrate, 3′,5′-Cyclic AMP dibutyrate, 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv., 6-[6-(butanoylamino)-9H-purin-9-yl]-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate, Actosin, Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate, Adenosine, N-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate, Bucladesin, Bucladesina, Butyramide, N-(9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-9H-purin-6-yl)-, 2′-butyrate, cyclic 3′,5′-phosphate, Butyramide, N-(9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-9H-purin-6-yl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, 2'-butyrate, cyclic 3',5'-phosphate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butyrate, Cyclic AMP N6,2'-O-dibutyrate, Cyclic AMP N⁶,2′-O-dibutyrate, Cyclic AMP dibutyrate, Cyclic dibutyryl-AMP, Dibutyryl 3',5'-cyclic AMP, Dibutyryl 3',5'-cyclic adenosine monophosphate, Dibutyryl 3′,5′-cyclic AMP, Dibutyryl 3′,5′-cyclic adenosine monophosphate, Dibutyryl adenosine 3',5'-cyclic monophosphate, Dibutyryl cAMP, Dibutyryl cyclic 3',5'-AMP, Dibutyryl cyclic 3',5'-adenylic acid, Dibutyryl cyclic 3′,5′-AMP, Dibutyryl cyclic 3′,5′-adenylic acid, Dibutyryl cyclic AMP, Dibutyryl cyclic adenosine 3',5'-monophosphate, Dibutyryl cyclic adenosine 3′,5′-monophosphate, Dibutyryl cyclic adenosine monophosphate, Dibutyryl-3',5'-AMP, Dibutyryl-3',5'-adenosine monophosphate, Dibutyryl-3′,5′-AMP, Dibutyryl-3′,5′-adenosine monophosphate, Dibutyryladenosine 3',5'-cyclic monophosphate, Dibutyryladenosine 3',5'-cyclic phosphate, Dibutyryladenosine 3',5'-cyclophosphate, Dibutyryladenosine 3',5'-monophosphate, Dibutyryladenosine 3′,5′-cyclic monophosphate, Dibutyryladenosine 3′,5′-cyclic phosphate, Dibutyryladenosine 3′,5′-cyclophosphate, Dibutyryladenosine 3′,5′-monophosphate, Dibutyryladenosine cyclic 3′,5′-monophosphate, Dibutyryladenosine cyclic monophosphate, Dt 5621, N-(9-beta-D-Ribofuranosyl-9H-furin-6-yl)-butyramide cyclic 3',5'-(hydrogen phosphate) 2'-butyrate, N-6,O-2'-Dibutyryl adenosine cyclic 3':5'-monophosphate, N-6-2-O-Dibutyryl adenosine-3',5'-monophosphate, N6,2'-Dibutyryladenosine cyclic 3',5'-(hydrogen phosphate), N6,2'-O-Dibutyryl 3',5'-cyclic adenosine monophosphate, N6,2'-O-Dibutyryl cAMP, N6,2'-O-Dibutyryl cyclic 3',5'-AMP, N6,2'-O-Dibutyryl cyclic 3',5'-adenosine monophosphate, N6,2'-O-Dibutyryl cyclic AMP, N6,2'-O-Dibutyryladenosine 3',5'-monophosphate, N6,2'-O-Dibutyryladenosine cyclic 3',5'-monophosphate, N6,2'-O-Dibutyryladenosine cyclic 3',5'-phosphate, N6,O2'-Dibutyryl 3',5'-AMP, N6,O2'-Dibutyryl adenosine 3',5'-cyclic monophosphate, N6,O2'-Dibutyryl adenosine-3',5'-phosphate, N6,O2'-Dibutyryl cyclic 3',5'-AMP, N6,O2'-Dibutyryl cyclic AMP, N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphate, N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphoric acid, N6,O2'-Dibutyryl cyclic adenosine monophosphate, N6,O2'-Dibutyryl-3',5'-cyclic AMP, N6,O2'-Dibutyryl-cAMP, N6,O2'-Dibutyryladenosine 3',5'-monophosphate, N6,O2'-Dibutyryladenosine cyclic 3',5'-phosphate, N6,O2'-Dibutyrylcyclic adenosine 3',5'-phosphate, N6-2'-O-Dibutyryl-3',5'-AMP, N₆-2′-O-Dibutyryl-3′,5′-AMP, N⁶,2′-Dibutyryladenosine cyclic 3′,5′-(hydrogen phosphate), N⁶,2′-O-Dibutyryl 3′,5′-cyclic adenosine monophosphate, N⁶,2′-O-Dibutyryl cAMP, N⁶,2′-O-Dibutyryl cyclic 3′,5′-AMP, N⁶,2′-O-Dibutyryl cyclic 3′,5′-adenosine monophosphate, N⁶,2′-O-Dibutyryl cyclic AMP, N⁶,2′-O-Dibutyryladenosine 3′,5′-monophosphate, N⁶,2′-O-Dibutyryladenosine cyclic 3′,5′-monophosphate, N⁶,2′-O-Dibutyryladenosine cyclic 3′,5′-phosphate, N⁶,O²′-Dibutyryl 3′,5′-AMP, N⁶,O²′-Dibutyryl adenosine 3′,5′-cyclic monophosphate, N⁶,O²′-Dibutyryl adenosine-3′,5′-phosphate, N⁶,O²′-Dibutyryl cyclic 3′,5′-AMP, N⁶,O²′-Dibutyryl cyclic adenosine monophosphate, N⁶,O²′-Dibutyryl-3′,5′-cyclic AMP, N⁶,O²′-Dibutyrylcyclic adenosine 3′,5′-phosphate, N⁶,O^2′-Dibutyryl cyclic AMP, N⁶,O^2′-Dibutyryl cyclic adenosine 3′,5′-monophosphate, N⁶,O^2′-Dibutyryl cyclic adenosine 3′,5′-monophosphoric acid, N⁶,O^2′-Dibutyryl-cAMP, N⁶,O^2′-Dibutyryladenosine 3′,5′-monophosphate, N⁶,O^2′-Dibutyryladenosine cyclic 3′,5′-phosphate, Nsc 143108, dbcAMP, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, 2′-butyrate, cyclic 3′,5′-phosphate

Descrizione

Dibutyryladenosine cyclic 3',5'-monophosphate (DBACMP) is a mitochondrial function regulator that inhibits the synthesis of ATP by binding to the methyltransferase enzyme. DBACMP also has an inhibitory effect on other enzymes, such as dna binding activity and enzyme activities involved in cellular energy metabolism. DBACMP inhibits infectious diseases by altering signal pathways, which leads to the production of cytokines and chemokines that have pro-inflammatory effects and stimulate axonal growth. The drug may also bind to the atp-binding cassette transporter and inhibit mitochondrial calcium uptake. DBACMP binds to polymorphonuclear leucocytes and alters cytosolic calcium levels, which may lead to an increased production of protein genes for cell growth.

• Marchio: Biosynth

Proprietà chimiche

• Peso molecolare: 469.39 g/mol
• Formula: C₁₈H₂₄N₅O₈P
• Purezza: Min. 95%